Cerity Partners LLC Acquires 116,607 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cerity Partners LLC lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 177.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 182,195 shares of the medical instruments supplier's stock after acquiring an additional 116,607 shares during the period. Cerity Partners LLC owned approximately 0.09% of DENTSPLY SIRONA worth $2,722,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in XRAY. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Norges Bank bought a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $45,730,000. AQR Capital Management LLC lifted its position in DENTSPLY SIRONA by 245.1% during the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock valued at $54,389,000 after purchasing an additional 2,054,767 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the last quarter. Finally, Invenomic Capital Management LP lifted its stake in shares of DENTSPLY SIRONA by 201.0% during the 4th quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock valued at $50,091,000 after buying an additional 1,762,428 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on XRAY shares. Barrington Research reissued an "outperform" rating and issued a $21.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target on the stock. in a research note on Tuesday, April 15th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday. Finally, UBS Group lowered their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Ten equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $19.60.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded up $0.78 on Tuesday, hitting $16.41. The company's stock had a trading volume of 5,992,792 shares, compared to its average volume of 2,925,800. The company has a market capitalization of $3.27 billion, a P/E ratio of -3.61, a price-to-earnings-growth ratio of 1.12 and a beta of 0.94. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The firm has a fifty day moving average price of $16.05 and a 200-day moving average price of $16.24. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same quarter last year, the company earned $0.42 earnings per share. The business's quarterly revenue was down 7.8% compared to the same quarter last year. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 3.90%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.